Sionna Therapeutics (SION) Cash from Operations (2024 - 2026)

Sionna Therapeutics has disclosed Cash from Operations across 3 years of filings, most recently posting 21840000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 21840000.0, down 34.09% year-over-year; the trailing twelve-month figure through Mar 2026 was 71849000.0 (down 28.53% YoY), and the FY2025 annual result was 66297000.0, down 25.59% from the prior year.
• Cash from Operations came in at 21840000.0 for Q1 2026 at Sionna Therapeutics, down from 16626000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 10145000.0 in Q2 2024 to a low of 21840000.0 in Q1 2026.
• The 3-year median for Cash from Operations is 16288000.0 (2025), against an average of 15658222.22.
• Peak annual rise in Cash from Operations reached 13.89% in 2025, while the deepest fall reached 78.94% in 2025.
• Sionna Therapeutics' Cash from Operations stood at 11781000.0 in 2024, then slumped by 41.13% to 16626000.0 in 2025, then slumped by 31.36% to 21840000.0 in 2026.
• The last three Cash from Operations figures came in at 21840000.0 (Q1 2026), 16626000.0 (Q4 2025), and 15230000.0 (Q3 2025), per Business Quant data.